Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-06

Clinical Trial Update: Flurbiprofen Axetil as an Adjuvant to Pre-emptive Scalp Infiltration [NA]

View source ↗

Summary

A clinical trial evaluating flurbiprofen axetil as an adjuvant to pre-emptive scalp infiltration for postoperative pain has been suspended; sponsor is Beijing T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flurbiprofen axetil (Flurbiprofen axetil)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Postoperative Pain | NA | Status: SUSPENDED